Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbzena Regulatory News (ABZA)

  • There is currently no data for ABZA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

11 Jan 2016 14:14

RNS Number : 4751L
Abzena PLC
11 January 2016
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

ABZENA PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

IMPERIAL INNOVATIONS GROUP PLC

4. Full name of shareholder(s)  (if different from 3.):iv

IMPERIAL INNOVATIONS BUSINESSES LLP

IMPERIAL INNOVATIONS LIMITED

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

11 DECEMBER 2015

6. Date on which issuer notified:

8 JANUARY 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

23%, 22%, 21%, 20%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

 

ORDINARY

22,953,452

22,953,452

27,120,102

27,120,102

19.9%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

27,120,102

19.9%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

William Rayner

General Counsel and Company Secretary

15. Contact telephone number:

020 3053 8859

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUAASRNAAAAAR
Date   Source Headline
11th Jan 20162:14 pmRNSHolding(s) in Company
6th Jan 20161:57 pmRNSLicensed product candidate update
5th Jan 20163:18 pmRNSBlocklisting Interim Review
18th Dec 20152:21 pmRNSHolding(s) in Company
15th Dec 201511:42 amRNSHolding(s) in Company
11th Dec 20154:12 pmRNSHolding(s) in Company
11th Dec 20153:13 pmRNSCompletion of Acquisition
10th Dec 201512:15 pmRNSResult of General Meeting
24th Nov 20157:00 amRNSPlacing to raise £20 million and acquisition
24th Nov 20157:00 amRNSHalf year results
21st Oct 20159:52 amRNSAppointment of joint broker
9th Oct 201512:34 pmRNSAdheron Therapeutics acquired by Roche
22nd Sep 201510:00 amRNSAGM Results
21st Sep 20157:00 amRNSPre-AGM Business Update
14th Sep 20157:00 amRNSAcquisition of PacificGMP
27th Aug 20153:37 pmRNSNotice of AGM
7th Aug 20157:00 amRNSExercise of Employee Share Options
7th Jul 20153:20 pmRNSBlock Admission
15th Jun 20151:03 pmRNSAnnual Financial Report
8th Jun 20157:00 amRNSResults for the year ended 31 March 2015
1st Jun 20157:00 amRNSNotice of Results
19th May 20157:00 amRNSCollaboration
13th May 20158:00 amRNSLicensed product candidate update
9th Apr 20157:00 amRNSProduct Development Update
2nd Apr 201510:36 amRNSExercise of Employee Share Options
9th Mar 20157:00 amRNSAppointment to Executive Management Team
2nd Mar 201512:51 pmRNSEdison initiates coverage of Abzena Plc
26th Feb 20154:23 pmRNSDirector Dealings
9th Feb 20157:00 amRNSProduct Development Update
6th Feb 20152:51 pmRNSHuman Tissue Authority licence application
12th Jan 20157:00 amRNSCollaboration
22nd Dec 20144:57 pmRNSDirector Dealings
12th Dec 20143:50 pmRNSDirector Dealings
11th Dec 20147:00 amRNSInterim Results
2nd Dec 20147:00 amRNSNotice of Results
21st Aug 20144:29 pmRNSResearch & Licence Agreement
4th Aug 20147:00 amRNSAbzena Completes Relocation
10th Jul 20148:02 amRNSFirst Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.